Guardant Health, Inc.
GH
$85.49
$1.471.75%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.06% | 14.27% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.06% | 14.27% | |||
| Cost of Revenue | 6.31% | 15.25% | |||
| Gross Profit | 5.92% | 13.74% | |||
| SG&A Expenses | 13.11% | 6.43% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.41% | 7.63% | |||
| Operating Income | -22.06% | 6.88% | |||
| Income Before Tax | -40.64% | 7.28% | |||
| Income Tax Expenses | -1,369.85% | 257.89% | |||
| Earnings from Continuing Operations | -38.58% | 7.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -38.58% | 7.18% | |||
| EBIT | -22.06% | 6.88% | |||
| EBITDA | -23.67% | 6.94% | |||
| EPS Basic | -34.43% | 7.70% | |||
| Normalized Basic EPS | -22.24% | 7.69% | |||
| EPS Diluted | -34.43% | 7.70% | |||
| Normalized Diluted EPS | -22.24% | 7.69% | |||
| Average Basic Shares Outstanding | 3.08% | 0.56% | |||
| Average Diluted Shares Outstanding | 3.08% | 0.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||